SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 399.93 |
| Enterprise Value ($M) | -18.00 |
| Book Value ($M) | 437.68 |
| Book Value / Share | 8.13 |
| Price / Book | 0.91 |
| NCAV ($M) | 378.52 |
| NCAV / Share | 7.03 |
| Price / NCAV | 1.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.18 |
| Return on Equity (ROE) | -0.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.00 |
| Current Ratio | 9.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 436.17 |
| Assets | 495.34 |
| Liabilities | 57.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 135.16 |
| Operating Income | -154.56 |
| Net Income | -122.31 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -150.05 |
| Cash from Investing | -0.30 |
| Cash from Financing | 1.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | EcoR1 Capital, LLC | 9.90 | -54.21 | |
| 13G/A | Scully William P | 10.30 | 37.71 | |
| 13G/A | Fennell Todd W. | 8.60 | 46.59 | |
| 13G/A | Wellington Management Group Llp | 9.50 | 22.78 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 7.10 | -9.91 | |
| 13G/A | State Street Corp | 3.10 | -39.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 261,997 | 1,481,456 | 17.69 | |
| 199,794 | 1,534,982 | 13.02 | |
| 178,352 | 1,571,519 | 11.35 | |
| 343,775 | 3,661,482 | 9.39 | |
| 312,581 | 2,183,744 | 14.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMVP – PMV Pharmaceuticals, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated | PTCT – PTC Therapeutics, Inc. |
| PYXS – Pyxis Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io